Free Trial

Rep. Bruce Westerman Sells Off Shares of The Procter & Gamble Company (NYSE:PG)

Procter & Gamble logo with Consumer Staples background

Representative Bruce Westerman (R-Arkansas) recently sold shares of The Procter & Gamble Company NYSE: PG. In a filing disclosed on May 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Procter & Gamble stock on April 21st. The trade occurred in the Representative's "FISHER IRA" account.

Representative Bruce Westerman also recently made the following trade(s):

  • Sold $1,001 - $15,000 in shares of UniCredit OTCMKTS: UNCRY on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of CSX NASDAQ: CSX on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of Siemens Aktiengesellschaft OTCMKTS: SIEGY on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of GSK NYSE: GSK on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of Charles Schwab NYSE: SCHW on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of The Goldman Sachs Group NYSE: GS on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of Abbott Laboratories NYSE: ABT on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of Eli Lilly and Company NYSE: LLY on 4/21/2025.
  • Sold $15,001 - $50,000 in shares of NVIDIA NASDAQ: NVDA on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of Chevron NYSE: CVX on 4/21/2025.

Procter & Gamble Price Performance

Shares of NYSE:PG traded up $1.75 during trading on Monday, reaching $165.03. 3,560,021 shares of the company traded hands, compared to its average volume of 7,222,266. The Procter & Gamble Company has a 52 week low of $156.58 and a 52 week high of $180.43. The company's 50 day moving average is $164.50 and its two-hundred day moving average is $167.31. The company has a quick ratio of 0.55, a current ratio of 0.76 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $386.91 billion, a PE ratio of 26.26, a PEG ratio of 3.76 and a beta of 0.41.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $1.54 earnings per share for the quarter, beating analysts' consensus estimates of $1.53 by $0.01. The company had revenue of $19.78 billion for the quarter, compared to analyst estimates of $20.42 billion. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. During the same quarter last year, the company earned $1.52 earnings per share. The company's revenue for the quarter was down 2.1% on a year-over-year basis. As a group, sell-side analysts predict that The Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Monday, April 21st were paid a dividend of $1.0568 per share. This is an increase from Procter & Gamble's previous quarterly dividend of $1.01. This represents a $4.23 annualized dividend and a dividend yield of 2.56%. The ex-dividend date of this dividend was Monday, April 21st. Procter & Gamble's payout ratio is currently 66.98%.

Insider Transactions at Procter & Gamble

In related news, CEO Gary A. Coombe sold 18,000 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, February 25th. The stock was sold at an average price of $171.66, for a total transaction of $3,089,880.00. Following the sale, the chief executive officer now directly owns 22,051 shares in the company, valued at $3,785,274.66. The trade was a 44.94% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Jennifer L. Davis sold 1,000 shares of Procter & Gamble stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total transaction of $161,380.00. Following the transaction, the chief executive officer now directly owns 51,965 shares of the company's stock, valued at $8,386,111.70. The trade was a 1.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 64,520 shares of company stock worth $10,999,268. Insiders own 0.18% of the company's stock.

Wall Street Analysts Forecast Growth

PG has been the subject of a number of analyst reports. Morgan Stanley set a $180.00 price objective on shares of Procter & Gamble and gave the company an "overweight" rating in a research note on Friday, April 25th. Erste Group Bank lowered Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Truist Financial reduced their target price on Procter & Gamble from $185.00 to $180.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Barclays reissued an "equal weight" rating on shares of Procter & Gamble in a report on Thursday, March 27th. Finally, Royal Bank of Canada upgraded Procter & Gamble from a "sector perform" rating to an "outperform" rating and increased their price target for the stock from $164.00 to $177.00 in a research report on Friday, April 25th. Eight analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, Procter & Gamble currently has a consensus rating of "Moderate Buy" and a consensus price target of $178.52.

View Our Latest Stock Report on Procter & Gamble

Institutional Investors Weigh In On Procter & Gamble

Institutional investors have recently bought and sold shares of the company. Lakeridge Wealth Management LLC boosted its holdings in Procter & Gamble by 0.6% during the fourth quarter. Lakeridge Wealth Management LLC now owns 10,807 shares of the company's stock worth $1,812,000 after buying an additional 60 shares in the last quarter. Unique Wealth LLC boosted its holdings in Procter & Gamble by 2.9% in the 1st quarter. Unique Wealth LLC now owns 2,141 shares of the company's stock worth $365,000 after acquiring an additional 61 shares during the period. Stableford Capital II LLC increased its position in Procter & Gamble by 1.1% in the first quarter. Stableford Capital II LLC now owns 5,817 shares of the company's stock worth $993,000 after buying an additional 61 shares during the period. Colton Groome Financial Advisors LLC boosted its position in Procter & Gamble by 3.2% during the 4th quarter. Colton Groome Financial Advisors LLC now owns 1,995 shares of the company's stock worth $334,000 after acquiring an additional 62 shares during the period. Finally, Bernard Wealth Management Corp. increased its position in Procter & Gamble by 20.2% in the 1st quarter. Bernard Wealth Management Corp. now owns 375 shares of the company's stock worth $64,000 after buying an additional 63 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.

About Representative Westerman

Bruce Westerman (Republican Party) is a member of the U.S. House, representing Arkansas' 4th Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027. Westerman (Republican Party) is running for re-election to the U.S. House to represent Arkansas' 4th Congressional District. He declared candidacy for the 2026 election. Westerman earned his BSBAGE in biological and agricultural engineering from the University of Arkansas in 1990 and his MF in forestry from Yale University in 2001. His professional experience includes working as a plant engineer for Riceland Foods and an engineer/forester for Mid-South Engineering Company.

Procter & Gamble Company Profile

(Get Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Further Reading

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines